Edition:
India

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

1.41USD
17 Nov 2017
Change (% chg)

$-0.06 (-4.08%)
Prev Close
$1.47
Open
$1.48
Day's High
$1.48
Day's Low
$1.38
Volume
22,713
Avg. Vol
46,004
52-wk High
$1.97
52-wk Low
$0.44

Select another date:

Tue, Nov 7 2017

BRIEF-Bellerophon Therapeutics reports Q3 loss per share $0.22

* Bellerophon provides business update and reports third quarter 2017 financial results

BRIEF-Bellerophon Therapeutics says selling stockholders may offer, resell up to 38.9 mln shares - SEC filing

* Bellerophon Therapeutics Inc files to say selling stockholders may offer and resell up to 38.9 million shares of co's common stock - SEC filing

BRIEF-Bellerophon announces $23 million private placement

* Bellerophon Therapeutics Inc - ‍financing was led by Puissance Capital Management and Venrock Healthcare Capital Partners​

BRIEF-Bellerophon announces positive top line Phase 2 data of INOpulse

* Bellerophon announces positive top line Phase 2 data of INOpulse for treatment of Pulmonary Hypertension associated with Chronic Obstructive Pulmonary Disease

BRIEF-Bellerophon reports Q2 loss per share $0.12

* Bellerophon reports second quarter 2017 financial results and provides business update

BRIEF-Bellerophon announces FDA agreement on phase 2B study design for Inopulse

* Bellerophon announces FDA agreement on phase 2B study design for Inopulse in pulmonary hypertension associated with interstitial lung disease (PH-ILD)

Select another date: